PCI Biotech Holding ASA - ESG Rating & Company Profile powered by AI
If you work at PCI Biotech Holding ASA and you wish to use your Sustainability rating, please contact us. The webpage contains a zero-cost Sustainability analysis covering PCI Biotech Holding ASA. This webpage contains a questions and answers section for PCI Biotech Holding ASA.
PCI Biotech Holding ASA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 5.3, social score of 3.2 and governance score of 4.0.
4.2
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
951 | Purple Biotech Ltd | 4.3 | High |
951 | Vectura Group Services Ltd | 4.3 | High |
969 | PCI Biotech Holding ASA | 4.2 | High |
969 | Botanix Pharmaceuticals Ltd | 4.2 | High |
969 | Arvinas Inc | 4.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does PCI Biotech Holding ASA have an accelerator or VC vehicle to help deliver innovation?
Does PCI Biotech Holding ASA disclose current and historical energy intensity?
Does PCI Biotech Holding ASA report the average age of the workforce?
Does PCI Biotech Holding ASA reference operational or capital allocation in relation to climate change?
Does PCI Biotech Holding ASA disclose its ethnicity pay gap?
Does PCI Biotech Holding ASA disclose cybersecurity risks?
Does PCI Biotech Holding ASA offer flexible work?
Does PCI Biotech Holding ASA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does PCI Biotech Holding ASA disclose the number of employees in R&D functions?
Does PCI Biotech Holding ASA conduct supply chain audits?
Does PCI Biotech Holding ASA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does PCI Biotech Holding ASA conduct 360 degree staff reviews?
Does PCI Biotech Holding ASA disclose the individual responsible for D&I?
Does PCI Biotech Holding ASA disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does PCI Biotech Holding ASA disclose current and / or historical scope 2 emissions?
Does PCI Biotech Holding ASA disclose water use targets?
Does PCI Biotech Holding ASA have careers partnerships with academic institutions?
Did PCI Biotech Holding ASA have a product recall in the last two years?
Does PCI Biotech Holding ASA disclose incidents of discrimination?
Does PCI Biotech Holding ASA allow for Work Councils/Collective Agreements to be formed?
Has PCI Biotech Holding ASA issued a profit warning in the past 24 months?
Does PCI Biotech Holding ASA disclose parental leave metrics?
Does PCI Biotech Holding ASA disclose climate scenario or pathway analysis?
Does PCI Biotech Holding ASA disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does PCI Biotech Holding ASA disclose the pay ratio of women to men?
Does PCI Biotech Holding ASA support suppliers with sustainability related research and development?
Does PCI Biotech Holding ASA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does PCI Biotech Holding ASA reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is PCI Biotech Holding ASA involved in embryonic stem cell research?
Does PCI Biotech Holding ASA disclose GHG and Air Emissions intensity?
Does PCI Biotech Holding ASA disclose its waste policy?
Does PCI Biotech Holding ASA report according to TCFD requirements?
Does PCI Biotech Holding ASA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does PCI Biotech Holding ASA disclose energy use targets?
Does PCI Biotech Holding ASA disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does PCI Biotech Holding ASA have a policy relating to cyber security?
Have a different question?
Potential Risks for PCI Biotech Holding ASA
These potential risks are based on the size, segment and geographies of the company.
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.